Feng Qinfu

Research areas: Comprehensive treatment of lung cancer, esophageal cancer, and thymic tumors; three-dimensional conformal radiotherapy; diagnosis and treatment of radiation-induced lung injury; intraoperative radiotherapy for tumors.

Cutting-edge technology: With 40 years of experience in radiotherapy, focusing on thoracic tumor radiotherapy since 1992, we have achieved top-tier domestic levels in the comprehensive treatment of lung cancer, esophageal cancer, thymic tumors, and prevention and treatment of radiation-induced lung injury. Intraoperative radiotherapy has been performed since 2000, with over 100 cases completed. We have developed a unique diagnostic and treatment system in areas such as dose protection of normal tissues in the spinal cord and cardiopulmonary system, optimization of stereotactic radiotherapy, and combined heavy ion and photon therapy.

Specializes in the comprehensive treatment of lung cancer, esophageal cancer, thymic tumors, and mediastinal tumors using radiotherapy, chemotherapy, targeted therapy, and immunotherapy.

Academic Highlights and Core Values: Chief Physician, Professor, and Master's Supervisor at the Cancer Hospital of the Chinese Academy of Medical Sciences; Head of the Pan-Beijing-Tianjin-Hebei Intraoperative Radiotherapy Collaboration Group of the Beijing Medical Association's Radiotherapy Branch. He has published approximately 70 papers, co-authored oncology monographs, and received numerous national and provincial-level research awards, including the Huaxia Medical Science and Technology Award and the Beijing Science and Technology Progress Award. As a specially appointed technical advisor for several cancer centers nationwide, he regularly travels between Beijing and Lanzhou campuses to provide clinical guidance and teaching.